Coastal Meds Recalls Cyanocobalamin Injectable Due to Particulate Matter
Coastal Meds, LLC. is recalling 745 vials of Cyanocobalamin Injectable due to the presence of unknown particulate matter.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk-of-harm product (injection) where injury has not yet been reported, fitting the 'High' severity criteria.
Plain-English summary
Coastal Meds, LLC. is recalling 745 vials of CYANOCOBALAMIN Injectable-30 mL MDV. The recall was initiated because of the presence of unknown particulate matter in the product.
The affected product was distributed nationwide in the USA. The specific lots involved are C/010218 (Discard by 07/01/2018), CAC/013118 (Discard by 4/1/2018), CAC/020518 (Discard by 4/6/2018), and CAC/021418 (Discard by 4/15/2018).
Consumers and healthcare providers should stop using the recalled product and contact Coastal Meds, LLC. for further instructions or a refund.
The recalled product
- Product
- CYANOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
- Manufacturer
- Coastal Meds, LLC.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 745
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: C/010218 Discard by 07/01/2018
- CAC/013118 Discard by 4/1/2018
- CAC/020518 Discard by 4/6/2018
- CAC/021418 Discard by 4/15/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Coastal Meds, LLC. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Coastal Meds, LLC.
See all →- SevereCoastal Meds Recalls LIPO-DEN PLUS Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
- HighFDA Recalls LIPO-DEN Injectable Due to Unknown Particulate Matter
FDA (Drugs) · 2018-05-02
- HighCoastal Meds Recalls Methylcobalamin Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
- SevereCoastal Meds Recalls Hydroxocobalamin Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
- SevereCoastal Meds Recalls Pyridoxine Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
Same hazard · particulate matter
See all →- ModerateIMAAVY Injection Recalled for Presence of Particulate Matter
FDA (Drugs) · 2026-10-14
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls Plum Administration Sets Due to Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
Similar recalls
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- ModerateCardinal Health Recalls Cyanocobalamin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- SevereAxium Healthcare Recalls Cyanocobalamin Injectables Due to Sterility Concerns
FDA (Drugs) · 2013-05-01
- SevereDowning Labs Recalls Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereMylan Recalls Cytarabine Injection Vials Due to Particulate Matter
FDA (Drugs) · 2015-08-19
- SevereFresenius Kabi Recalls Cyanocobalamin Vials Due to Sterility Concerns
FDA (Drugs) · 2014-12-17